OncoMed Pharmaceuticals Inc OMED Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

18:12 EDT 14 Mar 2018 | BioPortfolio Reports


OncoMed Pharmaceuticals Inc. OncoMed is a clinicalstage biopharmaceutical company that discovers and develops new anticancer therapies. The company developed pipeline candidates that obstruct the evasive mechanisms of tumor cells, increasing the visibility of such tumor cells, which leads to increasing attacks by the immune system and enhancing immune cell activity. Its clinical stage pipeline product candidates include navicixizumab, rosmantuzumab, GitrlFC Trimer, vantictumab, antiTIGIT, and ipafricept. OncoMed's expertise spans cancer research, drug discovery, clinical development, regulatory affairs, translational medicine and commercial development. It also develops targeted antibody and proteinbased therapies that help modulate and inhibit the growth of cancer stem cells CSC, which are also known as tumorinitiating cells. OncoMed is headquartered in Redwood, California, the US.

OncoMed Pharmaceuticals Inc Key Recent Developments

Jan 04,2018: OncoMed Provides 2018 Outlook and 2017 YearEnd Cash Balance and Announces an Update on the Rosmantuzumab Program

Jan 04,2018: OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings has Resigned

Nov 27,2017: OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities

Nov 02,2017: OncoMed Announces Third Quarter 2017 Financial Results and Operational Highlights

Aug 02,2017: OncoMed Announces Second Quarter 2017 Financial Results

This comprehensive SWOT profile of OncoMed Pharmaceuticals Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncoMed Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: OncoMed Pharmaceuticals Inc OMED Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300


More From BioPortfolio on "OncoMed Pharmaceuticals Inc OMED Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300"

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...